Martin Shkreli S E Trade Account Has Plummeted In Value
Shkreli’s E*Trade account, which consisted primarily of shares of KaloBios Pharmaceuticals, a drug company that the 32-year-old briefly ran, suffered a roughly $40 million drop in value since he posted bond in mid December. KaloBios filed for bankruptcy in December, which significantly affected the equity value of Shkreli’s E Trade brokerage account. Shkreli’s account is now worth roughly $4 million to $5 million, according to Assistant U.S. Attorney, Winston Paes....